| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $25.80B | $23.50B | $24.80B | $23.00B | $18.80B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $19.39B | $17.63B | $18.28B | $17.40B | $14.23B |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | $8.28B | $7.48B | $10.24B | $4.08B | $2.91B |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$802.00M | $339.00M | $1.01B | $586.00M | $348.00M |
| Net Income | $6.83B | $6.95B | $7.31B | $4.15B | $3.57B |
| EPS (basic) | 3.3100 | 3.3800 | 3.6100 | 2.1000 | 1.8200 |
| EPS (diluted) | 3.3000 | 3.3700 | 3.6000 | 2.1000 | 1.8100 |
| Shares (diluted) | $2.07B | $2.06B | $2.03B | $1.98B | $1.97B |